These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28247336)

  • 1. The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus.
    Chatziralli IP
    Diabetes Ther; 2017 Apr; 8(2):209-212. PubMed ID: 28247336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Glycemic Control and Variability in Diabetic Retinopathy.
    Chatziralli IP
    Diabetes Ther; 2018 Feb; 9(1):431-434. PubMed ID: 29190012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenofibrate for Diabetic Retinopathy.
    Stewart S; Lois N
    Asia Pac J Ophthalmol (Phila); 2018; 7(6):422-426. PubMed ID: 30058790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrates and statins in the treatment of diabetic retinopathy.
    Ansquer JC; Crimet D; Foucher C
    Curr Pharm Biotechnol; 2011 Mar; 12(3):396-405. PubMed ID: 20939802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index.
    Fenwick EK; Xie J; Pesudovs K; Ratcliffe J; Chiang PP; Finger RP; Lamoureux EL
    Clin Exp Optom; 2012 May; 95(3):362-70. PubMed ID: 22537275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic Retinopathy in Patients with Dyslipidemia: Development and Progression.
    Jeng CJ; Hsieh YT; Yang CM; Yang CH; Lin CL; Wang IJ
    Ophthalmol Retina; 2018 Jan; 2(1):38-45. PubMed ID: 31047300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate and diabetic retinopathy.
    Karti O; Saatci AO
    Med Hypothesis Discov Innov Ophthalmol; 2024; 13(1):35-43. PubMed ID: 38978827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
    Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes.
    Fenwick EK; Xie J; Ratcliffe J; Pesudovs K; Finger RP; Wong TY; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):677-84. PubMed ID: 22205611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Impact of Unilateral and Bilateral Classifications of Diabetic Retinopathy and Diabetic Macular Edema on Vision-Related Quality of Life.
    Man RE; Fenwick EK; Sabanayagam C; Li LJ; Tey CS; Soon HJ; Cheung GC; Tan GS; Wong TY; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4655-60. PubMed ID: 27603726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy.
    Sabanayagam C; Yip W; Ting DS; Tan G; Wong TY
    Ophthalmic Epidemiol; 2016 Aug; 23(4):209-22. PubMed ID: 27355693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.
    Keech AC; Mitchell P; Summanen PA; O'Day J; Davis TM; Moffitt MS; Taskinen MR; Simes RJ; Tse D; Williamson E; Merrifield A; Laatikainen LT; d'Emden MC; Crimet DC; O'Connell RL; Colman PG;
    Lancet; 2007 Nov; 370(9600):1687-97. PubMed ID: 17988728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managed care implications of diabetic macular edema.
    Holekamp NM
    Am J Manag Care; 2016 Jul; 22(10 Suppl):s300-s306. PubMed ID: 27668632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of diabetic retinopathy: evidence from large, randomized trials. The emerging role of fenofibrate.
    Simó R; Hernández C
    Rev Recent Clin Trials; 2012 Feb; 7(1):71-80. PubMed ID: 21864248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.
    Lee R; Wong TY; Sabanayagam C
    Eye Vis (Lond); 2015; 2():17. PubMed ID: 26605370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of manganese superoxide dismutase gene polymorphism (V16A) with diabetic macular edema in Korean type 2 diabetic patients.
    Lee SJ; Choi MG
    Metabolism; 2006 Dec; 55(12):1681-8. PubMed ID: 17142144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis.
    Xie J; Ikram MK; Cotch MF; Klein B; Varma R; Shaw JE; Klein R; Mitchell P; Lamoureux EL; Wong TY
    JAMA Ophthalmol; 2017 Jun; 135(6):586-593. PubMed ID: 28472362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Abnormal Renal Profiles and Proliferative Diabetic Retinopathy and Diabetic Macular Edema in an Asian Population With Type 2 Diabetes.
    Hsieh YT; Tsai MJ; Tu ST; Hsieh MC
    JAMA Ophthalmol; 2018 Jan; 136(1):68-74. PubMed ID: 29167896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fenofibrate on early retinal nerve fiber layer loss in type 2 diabetic patients: a case-control study.
    Shi R; Zhao L; Qi Y
    BMC Ophthalmol; 2018 Apr; 18(1):100. PubMed ID: 29669526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-mydriatic ultrawide field scanning laser ophthalmoscopy compared with dilated fundal examination for assessment of diabetic retinopathy and diabetic macular oedema in Chinese individuals with diabetes mellitus.
    Szeto SKH; Wong R; Lok J; Tang F; Sun Z; Tso T; Lam TCH; Tham CC; Ng DS; Cheung CY
    Br J Ophthalmol; 2019 Sep; 103(9):1327-1331. PubMed ID: 30381391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.